Predictors of Hematoma Expansion and Response to Andexanet in Patients With Intracerebral Hemorrhage: Secondary Analyses of the ANNEXA-I Randomized Clinical Trial.

Shoamanesh A, Connolly SJ, Demchuk AM, Seiffge DJ, Sandset EC, Molina CA, Tsivgoulis G, Christensen H, Beyer-Westendorf J, Coutinho JM, Amarenco P, Lemmens R, Veltkamp R, Middeldorp S, Zini A, Himmelmann A, Ladenvall P, Knutsson M, Xu L, Crowther M, Sharma M, ANNEXA-I Investigators

Open source

DOI: 10.1161/strokeaha.124.050418
Published: 2026 Jul
Container: Stroke
Publisher: Not recorded
Open access: yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
supportingOpen access status: Normalized open-access status: open. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1161/strokeaha.124.050418,
  title = {Predictors of Hematoma Expansion and Response to Andexanet in Patients With Intracerebral Hemorrhage: Secondary Analyses of the ANNEXA-I Randomized Clinical Trial.},
  author = {Shoamanesh A and Connolly SJ and Demchuk AM and Seiffge DJ and Sandset EC and Molina CA and Tsivgoulis G and Christensen H and Beyer-Westendorf J and Coutinho JM and Amarenco P and Lemmens R and Veltkamp R and Middeldorp S and Zini A and Himmelmann A and Ladenvall P and Knutsson M and Xu L and Crowther M and Sharma M and ANNEXA-I Investigators},
  year = {2026},
  journal = {Stroke},
  doi = {10.1161/strokeaha.124.050418},
  url = {https://doi.org/10.1161/strokeaha.124.050418}
}

RIS

TY  - JOUR
TI  - Predictors of Hematoma Expansion and Response to Andexanet in Patients With Intracerebral Hemorrhage: Secondary Analyses of the ANNEXA-I Randomized Clinical Trial.
AU  - Shoamanesh A
AU  - Connolly SJ
AU  - Demchuk AM
AU  - Seiffge DJ
AU  - Sandset EC
AU  - Molina CA
AU  - Tsivgoulis G
AU  - Christensen H
AU  - Beyer-Westendorf J
AU  - Coutinho JM
AU  - Amarenco P
AU  - Lemmens R
AU  - Veltkamp R
AU  - Middeldorp S
AU  - Zini A
AU  - Himmelmann A
AU  - Ladenvall P
AU  - Knutsson M
AU  - Xu L
AU  - Crowther M
AU  - Sharma M
AU  - ANNEXA-I Investigators
PY  - 2026
JO  - Stroke
DO  - 10.1161/strokeaha.124.050418
UR  - https://doi.org/10.1161/strokeaha.124.050418
ER  -

APA

A, S., SJ, C., AM, D., DJ, S., EC, S., CA, M., G, T., H, C., J, B., JM, C., P, A., R, L., R, V., S, M., A, Z., A, H., P, L., M, K., L, X., M, C., M, S., & Investigators, A. (2026). Predictors of Hematoma Expansion and Response to Andexanet in Patients With Intracerebral Hemorrhage: Secondary Analyses of the ANNEXA-I Randomized Clinical Trial.. Stroke. https://doi.org/10.1161/strokeaha.124.050418

Source records

pubmed · retrieved 2026-09-26T07:33:16.964Z